| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| R A Power, K J H Verweij, M Zuhair, G W Montgomery, A K Henders, A C Heath, P A F Madden, S E Medland, N R Wray, N G Marti. Genetic predisposition to schizophrenia associated with increased use of cannabis. Molecular psychiatry. vol 19. issue 11. 2015-07-13. PMID:24957864. |
genetic predisposition to schizophrenia associated with increased use of cannabis. |
2015-07-13 |
2023-08-13 |
Not clear |
| R A Power, K J H Verweij, M Zuhair, G W Montgomery, A K Henders, A C Heath, P A F Madden, S E Medland, N R Wray, N G Marti. Genetic predisposition to schizophrenia associated with increased use of cannabis. Molecular psychiatry. vol 19. issue 11. 2015-07-13. PMID:24957864. |
in a sample of 2082 healthy individuals, we show an association between an individual's burden of schizophrenia risk alleles and use of cannabis. |
2015-07-13 |
2023-08-13 |
Not clear |
| R A Power, K J H Verweij, M Zuhair, G W Montgomery, A K Henders, A C Heath, P A F Madden, S E Medland, N R Wray, N G Marti. Genetic predisposition to schizophrenia associated with increased use of cannabis. Molecular psychiatry. vol 19. issue 11. 2015-07-13. PMID:24957864. |
although directly predicting only a small amount of the variance in cannabis use, these findings suggest that part of the association between schizophrenia and cannabis is due to a shared genetic aetiology. |
2015-07-13 |
2023-08-13 |
Not clear |
| Abhishek Ghosh, Debasish Bas. Cannabis and psychopathology: The meandering journey of the last decade. Indian journal of psychiatry. vol 57. issue 2. 2015-06-30. PMID:26124519. |
the association between cannabis and schizophrenia has been researched more intensively. |
2015-06-30 |
2023-08-13 |
Not clear |
| Trevor Archer, Serafino Ricci, Danilo Garcia, Max Rapp Ricciard. Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders. Neurotoxicity research. vol 26. issue 4. 2015-06-23. PMID:24804834. |
the neurodegenerative and neurotoxic aspects of schizophrenia and/or psychosis involve genetic, epigenetic, and neurotoxic propensities that impinge upon both the symptom domains and the biomarkers of the disorder, involving cellular apoptosis/excitotoxicity, increased reactive oxygen species formation, viral and bacterial infections, anoxic birth injury, maternal starvation, drugs of abuse, particularly cannabis, metabolic accidents, and other chemical agents that disrupt normal brain development or the integrity of brain tissues. |
2015-06-23 |
2023-08-13 |
Not clear |
| David W Volk, Stephen M Eggan, Andrew G Horti, Dean F Wong, David A Lewi. Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia. Schizophrenia research. vol 159. issue 1. 2015-06-22. PMID:25107849. |
the deleterious effects of cannabis use in schizophrenia have been linked, in part, to underlying disturbances in endogenous cannabinoid signaling in the prefrontal cortex. |
2015-06-22 |
2023-08-13 |
human |
| David W Volk, Stephen M Eggan, Andrew G Horti, Dean F Wong, David A Lewi. Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia. Schizophrenia research. vol 159. issue 1. 2015-06-22. PMID:25107849. |
in either case, greater cb1r receptor availability may contribute to the increased susceptibility of schizophrenia subjects to the deleterious effects of cannabis use. |
2015-06-22 |
2023-08-13 |
human |
| b' Aleksandar Damjanovi\\xc4\\x87, Maja Pantovi\\xc4\\x87, Aleksandra Damjanovi\\xc4\\x87, Bojana Dunji\\xc4\\x87-Kosti\\xc4\\x87, Maja Ivkovi\\xc4\\x87, Sr\\xc4\\x91an Milovanovi\\xc4\\x87, Maja Lackovi\\xc4\\x87, Ivan Dimitrijevi\\xc4\\x8. Cannabis and psychosis revisited. Psychiatria Danubina. vol 27. issue 1. 2015-06-12. PMID:25751443.' |
the association between cannabinoids and psychosis has been known for almost a thousand years, but it is still speculated whether cannabis use may be a contributory cause of psychosis, that is, whether it may precipitate schizophrenia in those at risk. |
2015-06-12 |
2023-08-13 |
Not clear |
| b' Aleksandar Damjanovi\\xc4\\x87, Maja Pantovi\\xc4\\x87, Aleksandra Damjanovi\\xc4\\x87, Bojana Dunji\\xc4\\x87-Kosti\\xc4\\x87, Maja Ivkovi\\xc4\\x87, Sr\\xc4\\x91an Milovanovi\\xc4\\x87, Maja Lackovi\\xc4\\x87, Ivan Dimitrijevi\\xc4\\x8. Cannabis and psychosis revisited. Psychiatria Danubina. vol 27. issue 1. 2015-06-12. PMID:25751443.' |
in this paper, we will briefly present the data from individual longitudinal studies in the field, together with the factors that are considered important for the association of cannabis abuse and occurrence of schizophrenia and prevention opportunities in the target population. |
2015-06-12 |
2023-08-13 |
Not clear |
| Shawn Van Gerpen, Tamara Vik, Timothy J Sound. Medicinal and recreational marijuana: what are the risks? South Dakota medicine : the journal of the South Dakota State Medical Association. vol Spec No. 2015-06-09. PMID:25985611. |
several studies have shown increased rates of depression, anxiety and schizophrenia among those who use marijuana on a regular basis. |
2015-06-09 |
2023-08-13 |
Not clear |
| Adina S Fischer, Susan Whitfield-Gabrieli, Robert M Roth, Mary F Brunette, Alan I Gree. Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC. Schizophrenia research. vol 158. issue 1-3. 2015-05-26. PMID:25037524. |
impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: effects of cannabis and thc. |
2015-05-26 |
2023-08-13 |
human |
| Adina S Fischer, Susan Whitfield-Gabrieli, Robert M Roth, Mary F Brunette, Alan I Gree. Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC. Schizophrenia research. vol 158. issue 1-3. 2015-05-26. PMID:25037524. |
cannabis use disorder (cud) occurs in up to 42% of patients with schizophrenia and substantially worsens disease progression. |
2015-05-26 |
2023-08-13 |
human |
| Adina S Fischer, Susan Whitfield-Gabrieli, Robert M Roth, Mary F Brunette, Alan I Gree. Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC. Schizophrenia research. vol 158. issue 1-3. 2015-05-26. PMID:25037524. |
the basis of cud in schizophrenia is unclear and available treatments are rarely successful at limiting cannabis use. |
2015-05-26 |
2023-08-13 |
human |
| Adina S Fischer, Susan Whitfield-Gabrieli, Robert M Roth, Mary F Brunette, Alan I Gree. Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC. Schizophrenia research. vol 158. issue 1-3. 2015-05-26. PMID:25037524. |
in the present pilot study, we used whole-brain seed-to-voxel resting state functional connectivity (rs-fc) to examine the brc of patients with schizophrenia and cud, and to explore the effects of smoked cannabis and orally administered delta-9-tetrahydrocannabinol (thc) on the brc. |
2015-05-26 |
2023-08-13 |
human |
| Adina S Fischer, Susan Whitfield-Gabrieli, Robert M Roth, Mary F Brunette, Alan I Gree. Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC. Schizophrenia research. vol 158. issue 1-3. 2015-05-26. PMID:25037524. |
12 patients with schizophrenia and cud and 12 control subjects each completed two fmri resting scans, with patients administered either a 3.6% thc cannabis cigarette (n=6) or a 15 mg thc capsule (n=6) prior to their second scan. |
2015-05-26 |
2023-08-13 |
human |
| Adina S Fischer, Susan Whitfield-Gabrieli, Robert M Roth, Mary F Brunette, Alan I Gree. Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC. Schizophrenia research. vol 158. issue 1-3. 2015-05-26. PMID:25037524. |
this study is the first to investigate interregional connectivity of the brc and the effects of cannabis and thc on this circuit in patients with schizophrenia and cud. |
2015-05-26 |
2023-08-13 |
human |
| Katherine A Epstein, Kathryn R Cullen, Bryon A Mueller, Paul Robinson, Susanne Lee, Sanjiv Kumr. White matter abnormalities and cognitive impairment in early-onset schizophrenia-spectrum disorders. Journal of the American Academy of Child and Adolescent Psychiatry. vol 53. issue 3. 2015-04-13. PMID:24565363. |
to characterize white matter abnormalities in adolescents with early-onset schizophrenia (eos) relative to 3 comparison groups (adolescents at clinical high risk for developing schizophrenia [chr], adolescents with cannabis use disorder [cud], and healthy controls [hc]), and to identify neurocognitive correlates of white matter abnormalities in eos. |
2015-04-13 |
2023-08-12 |
Not clear |
| Matthew N Hil. Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia? Journal of psychiatry & neuroscience : JPN. vol 39. issue 2. 2015-04-02. PMID:24576402. |
clearing the smoke: what do we know about adolescent cannabis use and schizophrenia? |
2015-04-02 |
2023-08-12 |
Not clear |
| Benjamin B Tournier, Nathalie Ginovar. Repeated but not acute treatment with ∆⁹-tetrahydrocannabinol disrupts prepulse inhibition of the acoustic startle: reversal by the dopamine D₂/₃ receptor antagonist haloperidol. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 24. issue 8. 2015-03-30. PMID:24846537. |
cannabis produces cognitive dysfunctions that resemble those of schizophrenia; yet the neurobiological substrate of this similarity remains unclear. |
2015-03-30 |
2023-08-13 |
rat |
| Clifford M Cassidy, Martin Lepage, Ashok Mall. Do motivation deficits in schizophrenia-spectrum disorders promote cannabis use? An investigation of behavioural response to natural rewards and drug cues. Psychiatry research. vol 215. issue 3. 2015-03-18. PMID:24398065. |
subjects performed a behavioural task designed for schizophrenia patients in which they could seek exposure to pleasant and cannabis visual stimuli on the basis of internal representations of these stimuli. |
2015-03-18 |
2023-08-12 |
human |